Circadian rhythms are endogenous oscillations widely present in living organisms, typically following approximately 24-hour ...
Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in ...
Komal Jhaveri - Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, ...
The Brighterside of News on MSN
Breakthrough study finds that aging naturally protects against cancer
Most people assume that growing older only raises cancer risk. That idea feels natural because most diagnoses occur after 60.
Rakovina Therapeutics Inc., a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, has announced impressive results from its AI-enabled ATR program at the recent ...
Ipatasertib showed significant activity in patients with AKT1E17K mutations, with a 24.1% objective response rate and a median response duration of 10.1 months. The trial's 6-month progression-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback